In the domain of oncology, specifically for cancer therapy for lung cancer, erlotinib and osimertinib are two key medications.These medications, known for their effectiveness and precise method, have been revolutionizing cancer therapy.This article explores the intricacies of erlotinib and osimertinib, discussing four main requirements surrounding these drugs, with with the intent to offer a thorough knowledge of their functions in cancer therapy.The first need is to understand the action mechanism.The action mechanism of erlotinib and osimertinib involves blocking the tyrosine kinase action of the EGFR (EGFR).this suppression results in the…
